Search for: "Apotex Corp"
Results 301 - 320
of 333
Sort by Relevance
|
Sort by Date
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the generic… [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
15 Jan 2008, 3:06 am
Starent Networks Corp et al filed 05/08/07 1:07-cv-02683 Degregorio v. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
11 Dec 2007, 8:35 pm
By Donald Zuhn -- Last month, the Federal Circuit affirmed a District Court's finding on summary judgment that Merck & Co., Inc. had not obtained favorable rulings in two prior proceedings by fraud. [read post]
8 Dec 2007, 11:00 am
: (Peter Zura), Patent Tax: (Patent Prospector), (IP Spotlight), Patent litigation trends - survey results: (Patently'O), Admitting evidence of commercial success after KSR: (Delaware IP Law Blog), Abbott - A federal judge has stopped Abbott's attempt to add allegations to its claims against Johnson & Johnson subsidiary Cordis Corp in the ongoing drug eluting stent litigation: (IPLaw360), Abbott - Troll Busters Files… [read post]
6 Dec 2007, 7:27 pm
Merck & Co. (06-1405) Apotex Corp. appeals the decision of the United States District Court for the Northern District of Illinois1 granting summary judgment in favor of Merck & Co. in an action by Apotex to set aside a judgment on charges of fraud. [read post]
1 Dec 2007, 9:00 am
pharmaceutical companies: (SpicyIP),Great discussion on pharmaceuticals, patents and incentives for innovation: (Generic Pharmaceuticals & IP), (DrugWonks),Adenoscan (Adenosine) - Astellas Pharma, King Pharmaceuticals, and Teva Settle Adenoscan ® Patent Suit: (PatentDocs), Clarinex (Desloratadine) - Schering Corp. adds Anchen Pharmaceuticals Inc. to the long list of companies sued for patent infringement: (IPLaw360), Cosopt (dorzolamide hydrochloride and timolol maleate)… [read post]
23 Nov 2007, 9:00 am
: (SpicyIP), Moving towards the nano age: (SpicyIP), YouTube (Google) and T-Series copyright dispute: (SpicyIP), (TechWhack), JapanIP Value in Japan - the alternative view: (IAM),South KoreaSouth Korea has been urged to strengthen its intellectual property rules in order to sign a free trade agreement with the European Union: (Intellectual Property Watch)The NetherlandsDutch teenager arrested, and another five questioned by police, for allegedly stealing virtual furniture from… [read post]
21 Nov 2007, 5:21 am
Apotex, Inc., 432 F. [read post]
17 Nov 2007, 7:58 am
The conduct here was also arguably explainable, and did not rise to the necessary level to warrant setting aside the previous judgment.More detail of Apotex Corp. v. [read post]
18 Oct 2007, 10:33 pm
A long time ago - blogwise, anyway - we put together a post that described and linked to all the FDA's amicus curiae briefs that the Agency had filed in favor of preemption in prescription drug and medical device product liability litigation. [read post]
14 Oct 2007, 7:52 pm
The district court entered the following injunction: TorPharm, Inc., Apotex, Inc., Apotex Corp., and their respective affiliates, successors in interest, and assigns are enjoined from commercially manufacturing, using, selling, or offering to sell generic divalproex sodium which the Court has found to be infringing within the United States, or from importing such product into the United States, until Abbott's U.S. [read post]
10 Oct 2007, 8:29 pm
§ 271(e)(2)(A) and a judgement was ultimately granted in favor of Abbott on both validity and infringement where the the district court entered the following injunction:TorPharm, Inc., Apotex, Inc., Apotex Corp., and their respective affiliates, successors in interest, and assigns are enjoined from commercially manufacturing, using, selling, or offering to sell generic divalproex sodium which the Court has found to be infringing within the United States, or… [read post]
26 Sep 2007, 1:04 pm
AWH Corp., 415 F.3d 1303, 1327 (Fed. [read post]
23 Sep 2007, 2:28 pm
Apotex, Inc., 432 F. [read post]
6 Sep 2007, 8:13 am
Apotex, Inc., 432 F. [read post]
